Euphrosyne Gouzoulis‐Mayfrank

Impaired cognitive performance in drug free users of recreational ecstasy (MDMA)

Euphrosyne Gouzoulis‐Mayfrank · Journal of Neurology Neurosurgery & Psychiatry · 2000 · 309 citations · Full text

Neurometabolic Effects of Psilocybin, 3,4-Methylenedioxyethylamphetamine (MDE) and d-Methamphetamine in Healthy Volunteers A Double-Blind, Placebo-Controlled PET Study with [18F]FDG

Euphrosyne Gouzoulis‐Mayfrank · Neuropsychopharmacology · 1999 · 218 citations · Full text

Placebo-controlled Pet Study, Substance Abuse, Psychoactive Drug +8

Psychological Effects of (S)-Ketamine and N,N-Dimethyltryptamine (DMT): A Double-Blind, Cross-Over Study in Healthy Volunteers

Euphrosyne Gouzoulis‐Mayfrank, Karsten Heekeren, Anna Neukirch et al. · Pharmacopsychiatry · 2005 · 192 citations

Mismatch negativity generation in the human 5HT2A agonist and NMDA antagonist model of psychosis

Karsten Heekeren, Jörg Daumann, Anna Neukirch et al. · Psychopharmacology · 2008 · 156 citations · Full text

Memory impairment suggests hippocampal dysfunction in abstinent ecstasy users

Euphrosyne Gouzoulis‐Mayfrank, Bastian Thimm, Markus Rezk et al. · Progress in Neuro-Psychopharmacology and Biological Psychiatry · 2003 · 148 citations

Psychiatry, Addiction, Memory Loss +6